# Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.

> **NCT06505668** · NA · RECRUITING · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 40 (estimated)

## Conditions studied

- Treatment Resistant Schizophrenia
- Clozapine Adverse Reaction
- Heart Rate Variability
- Tachycardia

## Interventions

- **DRUG:** Atenolol 25 mg
- **DRUG:** Ivabradine 10mg

## Key facts

- **NCT ID:** NCT06505668
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06505668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06505668, "Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06505668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*